More than 73 million people in Russia received influenza vaccinations during 2025, according to data released by Rospotrebnadzor, the country's federal human wellbeing and consumer rights watchdog.
Russian medical specialists, including infectious disease expert Andrey Matyukhin, therapist Anna Shelobanova and editor Yulia Anasyan, detailed how modern vaccines work, where citizens can access them, and how to schedule inoculation ahead of seasonal infection peaks.
Vaccine Types and Biological Mechanisms
Modern influenza vaccines introduce the immune system to viral structures so that it learns to identify and destroy the virus without causing active illness. Standard preparations are categorized into three main biological categories based on the viral material utilized.
Inactivated influenza vaccines, known as IIV, represent the most common type and contain killed viruses or viral fragments unable to replicate or cause infection. Administered through intramuscular injection, inactivated vaccines carry no live pathogen and are considered the safest option, serving as the standard formulations used across Russia.
Live attenuated influenza vaccines, designated as LAIV, contain weakened live viruses that do not induce disease but generate a broader and more durable immune response. These preparations are typically delivered as a nasal spray, though they carry additional medical restrictions and are not recommended for pregnant women or individuals with immunodeficiency conditions.
Recombinant influenza vaccines, referred to as RIV, isolate specific viral proteins rather than using whole viral pathogens. Because recombinant formulations are produced without chicken embryos, they provide an alternative for individuals with severe egg protein allergies.
Vaccines are further categorized by the number of viral strains they target, divided into trivalent formulations protecting against two influenza A strains and one B strain, and quadrivalent formulations covering two A strains and two B strains. In accordance with World Health Organization guidelines, vaccine compositions in Russia are updated annually to match mutating viral strains.
Russian citizens can receive domestic vaccines such as Grippol, Grippol Plus, Sovigripp, and Ultrix, or imported preparations including Vaxigrip, Influvac, and Flu-M Tetra.
Medical studies demonstrate that vaccination reduces the overall risk of contracting influenza by 70 to 90 percent compared to unvaccinated individuals. For those who contract the virus despite vaccination, the illness presents in a milder form without severe complications.
Research cited by health experts indicates that flu vaccination decreases the risk of intensive care unit admission by 26 percent and reduces patient mortality by 31 percent compared to unvaccinated groups.
Safety Profile and Side Effects
Modern influenza vaccines are recognized among the safest preventive medical products available. Adverse side effects are generally limited to minor local reactions at the injection site, including temporary redness, mild pain, or localized swelling.
Systemic reactions occur rarely and may include mild headaches, physical weakness, or a low-grade fever up to 37.5 degrees Celsius, typically resolving within one to two days. Because inactivated vaccines contain no live viral particles, doctors stress that it is biologically impossible to contract influenza from the shot itself.
When an individual falls ill shortly after receiving a shot, health experts explain that the patient either contracted a non-flu acute respiratory viral infection or was already infected with influenza before vaccination, with the disease developing during its incubation phase.
Vaccination Locations and Procedures
Adults in Russia can obtain free influenza vaccinations at state polyclinics connected to their mandatory health insurance, known as OMI. Appointments can be scheduled through the Emias.Info mobile application or, for residents of Moscow, via the official mos.ru portal.
Free vaccinations are also provided at seasonal mobile stations that operate during annual vaccination drives. In 2025, Moscow established 18 mobile points located near metro, Moscow Central Circle, and Moscow Central Diameters stations, as well as inside major shopping centres and Multi-Functional Centres.
Mobile vaccination points operate on structured schedules, opening on weekdays from 08:00 to 20:00, on Saturdays from 09:00 to 18:00, and on Sundays from 09:00 to 16:00.
Citizens seeking to avoid queue times can visit private medical centers and private clinics. Private facilities charge for consultations and vaccine administration, offering flexible operating hours and access to imported preparations that may not be available in state clinics.
Prices for private vaccination services vary depending on the facility and selected vaccine, generally ranging between 1,500 and 4,000 rubles per dose.
No special dietary or medical preparation is needed before receiving a flu shot, although individuals must refrain from attending if they feel unwell. A general practitioner inspects each patient on the day of the appointment, evaluating overall health, measuring body temperature, and verifying the absence of contraindications before granting clearance.
Patients are advised to wear comfortable clothing providing easy access to the shoulder, as the injection is administered into the deltoid muscle, and to arrive early to complete registration paperwork. Attendees must present a Russian citizen passport and an OMI insurance policy, while private clinics may also request a SNILS individual insurance account number.
Health Risks and Medical Complications
Influenza is an acute viral infection characterized by sudden onset, high fever reaching 39 degrees Celsius or higher, severe headaches, muscle and joint pain, chills, and intense fatigue caused by aggressive influenza A and B viruses.
Infectious disease specialist Andrey Matyukhin, candidate of medical sciences at the Bud Zdorov clinic on Sretenka, warned that many patients underestimate influenza, attempting self-medication or leaving symptoms untreated. Matyukhin explained that the virus inflicts severe damage on respiratory mucosal linings within hours of infection, creating pathways for secondary bacterial invasions.
Pulmonary complications represent the most frequent and dangerous outcomes, with pneumonia and bronchitis cited as leading causes of death among influenza patients. Other severe consequences include ear, nose, and throat infections such as otitis, sinusitis, rhinitis, and tracheitis.
Cardiovascular complications from influenza include myocarditis and pericarditis, while nervous system damage can manifest as meningitis, meningoencephalitis, encephalitis, and neuralgia.
Anna Shelobanova, a therapist and gerontologist with the Teplye Besedy network of boarding houses for the elderly, stated that vaccination for adults aged 30 to 60 is essential to preserve physiological resources, prevent long-term organ strain, and maintain daily activity levels.
For elderly individuals, Shelobanova emphasized that vaccination prevents a domino effect where influenza triggers acute flare-ups of underlying chronic conditions, such as hypertension or early-stage diabetes.
Severe viral infections accelerate microvascular damage, increasing risks of cognitive decline and heart conditions. Shelobanova noted that influenza triggers a powerful systemic inflammatory response in older adults that frequently induces heart attacks and strokes, making vaccination a key protective measure for blood vessels and cardiac health.
Optimal Timing and Seasonal Scheduling
Dr. Matyukhin stated that the optimal window for flu vaccination is in autumn, specifically between September and October.
The body requires between two and four weeks following injection to build a full immune response, allowing antibody levels to reach protective thresholds. Inoculation in September or October ensures robust immunity before regional infection rates begin rising in November and December.
Vaccine-induced immunity remains effective for 6 to 12 months. Scheduling shots too early in July or August may result in declining antibody levels toward the end of the flu season while viral strains are still circulating.
Dr. Matyukhin emphasized that as long as influenza viruses remain active in the community, it is never too late to get vaccinated, noting that shots remain beneficial throughout January and February.
He cautioned that receiving a vaccine during peak epidemic periods carries a minor risk that a person may already be infected, as the standard incubation period lasts between one and four days. In such cases, illness may emerge shortly after the shot before the vaccine has had sufficient time to generate protection.
Medical Contraindications and Age Rules
Contraindications for influenza vaccination are categorized into permanent absolute restrictions and temporary delays, according to Dr. Matyukhin.
Absolute contraindications that permanently prohibit vaccination include severe allergic reactions to previous doses, such as anaphylaxis or Quincke's edema. Permanent prohibitions also apply to patients who experienced severe post-vaccine complications, such as Guillain-Barre syndrome within six weeks of a previous shot.
Severe allergies to specific vaccine components, including chicken egg protein used during viral cultivation or trace amounts of antibiotics such as neomycin and gentamicin, also constitute absolute contraindications.
Temporary contraindications require postponing vaccination until health normalizes. Inoculations are delayed for two to four weeks following recovery from acute infectious or non-infectious illnesses, or after achieving remission from chronic disease flare-ups.
Elevated body temperature requires delaying the shot until readings return to normal. Patients recovering from mild acute respiratory viral infections or mild intestinal tract infections can receive vaccines immediately once their temperature stabilizes.
Age alone is not a restriction, as specialized formulations exist for pediatric patients starting from six months of age as well as enhanced-response vaccines for elderly populations. Final determination regarding contraindications rests with an examining physician.
Post-Vaccination Monitoring and Care
Physical responses following flu shots are generally benign signs that the immune system is recognizing viral antigens. Local reactions such as redness, mild pain, or swelling at the injection site typically resolve within two to three days.
Systemic responses including low-grade fever up to 37.5 degrees Celsius during the first 24 hours, mild headaches, physical fatigue, and muscle discomfort are temporary and usually require no specific medical intervention.
Health experts advise patients to rest and maintain fluid intake after vaccination. Prophylactic antipyretic medications should be avoided, as taking fever reducers without cause can diminish the strength of the body's immune response.
If fever causes significant discomfort, paracetamol or ibuprofen may be taken following medical consultation. Immediate medical attention is required if body temperature exceeds 38.5 degrees Celsius, if fever persists beyond two days, or if patients experience skin rashes, severe headaches, or breathing difficulties.
Dr. Matyukhin advised that individuals who develop respiratory symptoms after receiving a shot should contact a doctor, refrain from self-medication, request sick leave, and remain at home, noting that such illnesses reflect exposure prior to immunity development rather than an adverse effect of the vaccine.
